Skip to content

Clinical trials

Dysbiosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dysbiosis Country / region: United States Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20141
20161
20172
20185
20194
20204
20211
20224
20235
20243
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting7
Active, not recruiting6
Not yet recruiting4
Withdrawn2
Terminated2
Enrolling by invitation1
Unknown status1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Florida State University5
National Institute of Allergy and Infectious Diseases (NIAID)3
Boston Medical Center2
Emory University2
Ohio State University2
ProgenaBiome2
University of California, Davis2
3 Waves Wellness1
Acibadem Maslak Hospital1
Albert Einstein College of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dysbiosis43
Inflammation6
HIV Infections4
Aging, Premature2
Atrophic Vaginitis2
Cardiovascular Diseases2
Clostridium Infections2
Critical Illness2
Endotoxemia2
Inflammatory Bowel Diseases2

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.